PPARδ激动剂通过激活AKT/mTOR信号通路介导的自来保护骨关节炎
Guantong Sun1, Xiaodong Li1, Pengcheng Liu2
1Department of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
向氧酶增殖器激活受体三角形 (PPARδ) 可能治疗关节炎 (OA). 在OA模型中,PPARδ激活减少了软骨降解和细胞死亡,这表明了这种常见关节疾病的潜在治疗方法.
科学领域:
- 生物医学研究的研究.
- 类风湿病学 类风湿病学
- 分子生物学分子生物学
背景情况:
- 骨关节炎 (OA) 是一种普遍存在的退行性关节疾病.
- 过氧体增殖器激活受体 (PPAR) 参与了OA的发病.
- 在OA发展中PPARδ的确切作用尚不清楚.
研究的目的:
- 调查PPARδ对骨关节炎发病和进展的影响.
- 阐明PPARδ对OA冠状细胞影响的机制.
主要方法:
- 在体外研究中使用IL-1β刺激的OA胆固醇细胞.
- 在体内实验涉及中介阴茎 (DMM) 鼠标OA模型不稳定的实验.
- 将PPARδ激动剂注射到关节腔中.
主要成果:
- 在试验室中PPARδ激活减少了冠状细胞亡和细胞外基质 (ECM) 降解.
- PPARδ激活调节了AKT/mTOR信号传递,影响了冠状细胞自和亡.
- 在体内,PPARδ激动剂治疗改善了ECM完整性,减少了亡和自,并延迟了OA大鼠的软骨退化.
结论:
- PPARδ激活显示了对关节炎进展的保护作用.
- 向PPARδ代表了骨关节炎治疗的潜在治疗策略.
更多相关视频
07:58Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
Published on: February 25, 2014
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
